Back
AddLife AB Vs. Calliditas Therapeutics AB Industry Stock Comparison
Sell
36
ADDLF
AddLife AB
Last Price:
42.00
Seasonality Move:
0%
Buy
81
CALT
Calliditas Therapeutics AB
Last Price:
21.63
Seasonality Move:
13.77%
Sell
36
AddLife AB (ADDLF)
is a Sell
Is AddLife AB a Buy, Sell or Hold?
- The current AddLife AB [ADDLF] share price is $42.00. The Score for ADDLF is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- ADDLF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
81
Calliditas Therapeutics AB (CALT)
is a Buy
Is Calliditas Therapeutics AB a Buy, Sell or Hold?
- The current Calliditas Therapeutics AB [CALT] share price is $22.19. The Score for CALT is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
- CALT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
ADDLF Stock Price Chart
What is AddLife AB's stock price today?
-
The AddLife AB share price today is $42.00
The current trend is relatively stagnant and ADDLF is experiencing slight buying pressure.
CALT Stock Price Chart
What is Calliditas Therapeutics AB's stock price today?
-
The Calliditas Therapeutics AB share price today is $22.19
The current trend is moderately bullish and CALT is experiencing buying pressure, which is a positive indicator for future bullish movement.
ADDLF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Sell |
| Relative Strength Index (14 RSI): | 93.14 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42 - 42) | Sell |
| Bollinger Bands (100): | (42 - 42) | Sell |
CALT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.51 | Buy |
| Relative Strength Index (14 RSI): | 61.28 | Buy |
| Chaikin Money Flow: | 754 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.41 - 21.21) | Buy |
| Bollinger Bands (100): | (19.7 - 23.76) | Buy |
ADDLF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42 | Sell |
| 20-day SMA: | 42 | Sell |
| 50-day SMA: | 42 | Sell |
| 200-day SMA: | 42 | Sell |
| 8-day EMA: | 42 | Sell |
| 20-day EMA: | 42 | Sell |
| 50-day EMA: | 42 | Sell |
| 200-day EMA: | 41.41 | Buy |
CALT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.42 | Buy |
| 20-day SMA: | 20.17 | Buy |
| 50-day SMA: | 20.71 | Buy |
| 200-day SMA: | 19.79 | Buy |
| 8-day EMA: | 21.53 | Buy |
| 20-day EMA: | 20.76 | Buy |
| 50-day EMA: | 20.67 | Buy |
| 200-day EMA: | 20.29 | Buy |
AddLife AB Earnings Growth & ADDLF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Calliditas Therapeutics AB Earnings Growth & CALT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.06 per share, and an increase next year of $2.00 per share.
AddLife AB Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Calliditas Therapeutics AB Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||